Does THIOTEPA Cause Bronchopulmonary aspergillosis? 73 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 73 reports of Bronchopulmonary aspergillosis have been filed in association with THIOTEPA (Thiotepa). This represents 1.1% of all adverse event reports for THIOTEPA.
73
Reports of Bronchopulmonary aspergillosis with THIOTEPA
1.1%
of all THIOTEPA reports
17
Deaths
21
Hospitalizations
How Dangerous Is Bronchopulmonary aspergillosis From THIOTEPA?
Of the 73 reports, 17 (23.3%) resulted in death, 21 (28.8%) required hospitalization, and 8 (11.0%) were considered life-threatening.
Is Bronchopulmonary aspergillosis Listed in the Official Label?
Yes, Bronchopulmonary aspergillosis is listed as a known adverse reaction in the official FDA drug label for THIOTEPA.
What Other Side Effects Does THIOTEPA Cause?
Off label use (762)
Febrile neutropenia (645)
Mucosal inflammation (616)
Cytomegalovirus infection (446)
Product use in unapproved indication (425)
Pyrexia (359)
Drug ineffective (358)
Acute graft versus host disease in skin (355)
Acute graft versus host disease (331)
Cytomegalovirus infection reactivation (325)
What Other Drugs Cause Bronchopulmonary aspergillosis?
TACROLIMUS (968)
PREDNISONE (967)
DEXAMETHASONE (854)
CYCLOPHOSPHAMIDE (824)
METHYLPREDNISOLONE (794)
PREDNISOLONE (704)
MYCOPHENOLATE MOFETIL (702)
RITUXIMAB (606)
CYCLOSPORINE (583)
METHOTREXATE (553)
Which THIOTEPA Alternatives Have Lower Bronchopulmonary aspergillosis Risk?
THIOTEPA vs THIOTHIXENE
THIOTEPA vs THROMBIN
THIOTEPA vs THROMBIN HUMAN
THIOTEPA vs THYMOCYTE IMMUNE GLOBULIN NOS
THIOTEPA vs THYMOGLOBULINE